Oman
With over two decades of experience in pharmaceutical manufacturing, I currently serve as the Chief Executive Officer at Pen-G. I focus on driving strategic leadership, operational efficiency, and regulatory compliance to ensure the delivery of high-quality penicillin products. My role involves overseeing and optimizing core functions, including Sales, Production, Finance, Logistics, IT systems, and process implementation to position the company as a global leader in the penicillin market. My career spans significant leadership roles at Novartis, Sandoz, and Centrient Pharmaceuticals, where I contributed to manufacturing operations, supply chain management, and global health initiatives. My approach combines strong leadership and communication skills with a commitment to working smart and achieving excellence through setting and meeting clear objectives.
Drive the overall strategic leadership, business planning, operational efficiency, and financial performance of the company. Ensure alignment of all functions with the company’s mission of delivering high quality products while maintaining regulatory compliance and achieving profitability. Lead, mentor and optimize all aspects of the company's operations, including Sales, Production, Finance, Logistics, IT systems, and process implementation. Leads efforts in process optimization, product expansion, regulatory compliance, and stakeholder engagement, positioning the plant as a leader in the global penicillin market. Demonstrate excellent intellectual and emotional leadership to inspire and mentor a workforce of highly qualified scientists and technicians operating extremely sensitive production processes in order to achieve the optimum product yields. Build and maintain strong relationships with key stakeholders, including regulatory bodies and governmental entities.
Management of site activities in the manufacturing of API Intermediates and Immobilized Enzymes. Impact on global health: facilitating 1.5 bio treatments / year worldwide
Manufacturing Unit Oral Penicillins and Cefalosporins. Production of Bulk and Final Packaging operations.
End-2-End Supply Chain Management of Active Pharmaceutical Ingredients (API) and Final Dosage Forms (FDF) Business for Anti-Infectives. Production Planning, Logistics-Warehouse Management and distribution of API and finished goods, Customer Service Agency and Materials Management. Financial responsibility. Size of the team managed: 150 employees reduced to 77 through transformation projects.
Design, planning, execution, control, and monitoring of supply chain activities in the synthesis of Active Pharmaceutical Ingredients (API). Management of compliance activities and audits from customers / authorities.
Production of Bulk Active Pharmaceutical Ingredients via Fermentation and Chemical Technologies. Responsibility of the whole production asset (Microbiology, Fermentation, Downstream Processing, Chemical Synthesis, Finishing & Packaging, Solvent Recovery & Recycling). Production Planning and Budgeting. Organization and Training of Personnel.
Production of Bulk Active Pharmaceutical Ingredients via purification steps and Chemical Synthesis, Finishing & Packaging, Solvent Recovery & Recycling, process development. Production Planning and Budgeting. Organization and Training of Personnel.
Managing of Laboratory Activities and Publications. Managing of Projects, Budgeting and Staff.